154 related articles for article (PubMed ID: 15620452)
21. [Prevalence of vaginal candidiasis in pregnant women. Identification of yeasts and susceptibility to antifungal agents].
García Heredia M; García SD; Copolillo EF; Cora Eliseth M; Barata AD; Vay CA; de Torres RA; Tiraboschi N; Famiglietti AM
Rev Argent Microbiol; 2006; 38(1):9-12. PubMed ID: 16784126
[TBL] [Abstract][Full Text] [Related]
22. Identification of Candida species isolated from patients in intensive care unit and in vitro susceptibility to fluconazole for a 3-year period.
Comert F; Kulah C; Aktas E; Eroglu O; Ozlu N
Mycoses; 2007 Jan; 50(1):52-7. PubMed ID: 17302749
[TBL] [Abstract][Full Text] [Related]
23. [Multicenter study of fungemia due to yeasts in Argentina].
Rodero L; Davel G; Soria M; Vivot W; Córdoba S; Canteros CE; Saporiti A;
Rev Argent Microbiol; 2005; 37(4):189-95. PubMed ID: 16502638
[TBL] [Abstract][Full Text] [Related]
24. Antifungal susceptibility of Candida spp. isolated from pediatric patients: a survey of 4 children's hospitals.
Zaoutis TE; Foraker E; McGowan KL; Mortensen J; Campos J; Walsh TJ; Klein JD
Diagn Microbiol Infect Dis; 2005 Aug; 52(4):295-8. PubMed ID: 15922535
[TBL] [Abstract][Full Text] [Related]
25. Candida albicans versus non-albicans bloodstream infection in patients in a tertiary hospital: an analysis of microbiological data.
Samonis G; Kofteridis DP; Saloustros E; Giannopoulou KP; Ntziora F; Christidou A; Maraki S; Falagas ME
Scand J Infect Dis; 2008; 40(5):414-9. PubMed ID: 18418802
[TBL] [Abstract][Full Text] [Related]
26. Diversity and antifungal susceptibility of yeasts from tropical freshwater environments in Southeastern Brazil.
Medeiros AO; Kohler LM; Hamdan JS; Missagia BS; Barbosa FA; Rosa CA
Water Res; 2008 Aug; 42(14):3921-9. PubMed ID: 18678387
[TBL] [Abstract][Full Text] [Related]
27. Emergence of non-albicans Candida species and antifungal resistance in a tertiary care hospital.
Capoor MR; Nair D; Deb M; Verma PK; Srivastava L; Aggarwal P
Jpn J Infect Dis; 2005 Dec; 58(6):344-8. PubMed ID: 16377864
[TBL] [Abstract][Full Text] [Related]
28. Invasive Candida species infections: a 5 year population-based assessment.
Laupland KB; Gregson DB; Church DL; Ross T; Elsayed S
J Antimicrob Chemother; 2005 Sep; 56(3):532-7. PubMed ID: 16040623
[TBL] [Abstract][Full Text] [Related]
29. Prevalence of Candida species in different hospital wards and their susceptibility to antifungal agents: results of a three year survey.
Fadda ME; Podda GS; Pisano MB; Deplano M; Cosentino S
J Prev Med Hyg; 2008 Jun; 49(2):69-74. PubMed ID: 18847180
[TBL] [Abstract][Full Text] [Related]
30. High frequency of yeast carriage on hands of hospital personnel.
Strausbaugh LJ; Sewell DL; Ward TT; Pfaller MA; Heitzman T; Tjoelker R
J Clin Microbiol; 1994 Sep; 32(9):2299-300. PubMed ID: 7814563
[TBL] [Abstract][Full Text] [Related]
31. [Candida carriage in the oral mucosa of a student population: adhesiveness of the strains and predisposing factors].
Negroni M; González MI; Levin B; Cuesta A; Iovanniti C
Rev Argent Microbiol; 2002; 34(1):22-8. PubMed ID: 11942080
[TBL] [Abstract][Full Text] [Related]
32. Changing distribution of Candida species isolated from sterile and nonsterile sites in Israel.
Samra Z; Bishara J; Ashkenazi S; Pitlik S; Weinberger M; Lapidoth M; Yardeni M; Levy I
Eur J Clin Microbiol Infect Dis; 2002 Jul; 21(7):542-5. PubMed ID: 12172747
[TBL] [Abstract][Full Text] [Related]
33. Virulence factors, antifungal susceptibility and molecular profile in Candida species isolated from the hands of health professionals before and after cleaning with 70% ethyl alcohol-based gel.
Alves PGV; Menezes RP; Silva NBS; Faria GO; Bessa MAS; de Araújo LB; Aguiar PADF; Penatti MPA; Pedroso RDS; Röder DVDB
J Mycol Med; 2024 Jun; 34(2):101482. PubMed ID: 38763122
[TBL] [Abstract][Full Text] [Related]
34. Epidemiologic analysis and antifungal susceptibility of Candida blood isolates in southern Taiwan.
Chen TC; Chen YH; Tsai JJ; Peng CF; Lu PL; Chang K; Hsieh HC; Chen TP
J Microbiol Immunol Infect; 2005 Jun; 38(3):200-10. PubMed ID: 15986071
[TBL] [Abstract][Full Text] [Related]
35. Antifungal susceptibility of clinical Candida parapsilosis isolates in Kuwait.
Asadzadeh M; Al-Sweih NA; Ahmad S; Khan ZU
Mycoses; 2008 Jul; 51(4):318-23. PubMed ID: 18855844
[TBL] [Abstract][Full Text] [Related]
36. The trend of susceptibilities to amphotericin B and fluconazole of Candida species from 1999 to 2002 in Taiwan.
Yang YL; Li SY; Cheng HH; Lo HJ;
BMC Infect Dis; 2005 Nov; 5():99. PubMed ID: 16266438
[TBL] [Abstract][Full Text] [Related]
37. In vitro antifungal susceptibility of clinical isolates of Candida spp. obtained from patients with different predisposing factors to candidosis.
Pinto PM; Weikert-Oliveira Rde C; Lyon JP; Cury VF; Arantes RR; Koga-Ito CY; Resende MA
Microbiol Res; 2008; 163(5):579-85. PubMed ID: 16962755
[TBL] [Abstract][Full Text] [Related]
38. In vitro susceptibility of Candida species isolated from blood culture to some antifungal agents.
Citak S; Ozçelik B; Cesur S; Abbasoğlu U
Jpn J Infect Dis; 2005 Feb; 58(1):44-6. PubMed ID: 15728993
[TBL] [Abstract][Full Text] [Related]
39. [In vitro activity of amphotericin B, fluconazole and itraconazole against Candida glabrata strains isolated from clinical samples].
Hüseyin A; Sancak B; Arikan S
Mikrobiyol Bul; 2007 Apr; 41(2):235-44. PubMed ID: 17682710
[TBL] [Abstract][Full Text] [Related]
40. Virulence of Candida parapsilosis, Candida orthopsilosis, and Candida metapsilosis in reconstituted human tissue models.
Gácser A; Schäfer W; Nosanchuk JS; Salomon S; Nosanchuk JD
Fungal Genet Biol; 2007 Dec; 44(12):1336-41. PubMed ID: 17391997
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
